Sempra
Congress has disclosed 15 buys and 14 sells of SRE (Sempra) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying SRE and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2025-10-17 | $88.62 | $84.87 | -4.2% | ↩ near entry |
| Ritchie John Torres | 2024-09-26 | $77.06 | $84.87 | +10.1% | in profit |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Utilities. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Utilities). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HRES 1611 | Expressing support for the designation of October 8, 2026, as "National Hydrogen and Fuel Cell Day". | Energy | 2026-10-05 |
| S 5249 | MORE American Fuel Act of 2026 | Energy | 2026-10-05 |
| HR 10684 | DOE Bioenergy Program Reauthorization Act | Energy | 2026-10-01 |
| HR 9340 | Ratepayer Protection Act | Energy | 2026-09-30 |
| SRES 936 | A resolution designating October 8, 2026, as "National Hydrogen and Fuel Cell Day". | Energy | 2026-09-30 |
29 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -0.5% | $1K–$15K 0.1% of NW |
28.1 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -0.5% | $1K–$15K 0.1% of NW |
33.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-10-17 | 18 days | +1.3% | $1K–$15K | 59.8 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Merrill Lynch Long Term Growth | 2025-09-25 | 12 days | +9.5% | $1K–$15K <0.1% of NW |
13.1 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Merrill Lynch Tax Efficient Core | 2025-09-23 | 14 days | +10.0% | $1K–$15K <0.1% of NW |
62.8 | ↗ filing |
| Julie Johnson | House | BUY ◆ insider divergence · moderate | Joint · Merrill Lynch Long Term Growth | 2025-09-23 | 14 days | +10.0% | $1K–$15K <0.1% of NW |
66.5 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-06-26 | 77 days | +11.4% | $1K–$15K 0.8% of NW |
30.2 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | +12.0% | $1K–$15K 0.1% of NW |
63.6 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider convergence · strong | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
28.5 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider divergence · strong | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider divergence | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +2.4% | $1K–$15K 0.8% of NW |
65.6 | ↗ filing |
| Ritchie John Torres | House | BUY ◆ insider divergence | Self | 2024-09-26 | 309 days | +1.3% | $1K–$15K 3.2% of NW 🔥 |
85.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2023-07-03 | 29 days | — | $1K–$15K | 86.8 | ↗ filing |
| Dwight Evans | House | BUY | Self · PERSHING LLC | 2023-06-22 | 6 days | — | $1K–$15K 0.8% of NW |
52.4 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
| Dwight Evans | House | BUY | Self · PROEQUITIES | 2022-11-14 | 4 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
| Rick Larsen | House | SELL | Self · Richard R Larsen IRA > Ameriprise SPS Managed Account | 2021-07-01 | 686 days | — | $1K–$15K 0.7% of NW |
75.9 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-04-02 | 34 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2019-10-31 | 6 days | — | $1K–$15K | 8.6 | ↗ filing |
| Donna Shalala | House | SELL | Self | 2019-08-28 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2019-03-27 | 20 days | — | $1K–$15K | 10.6 | ↗ filing |
| Donna Shalala | House | SELL | Self | 2019-02-05 | 23 days | — | $1K–$15K | 75.9 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2018-10-25 | 6 days | — | $1K–$15K | 15.7 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2018-10-24 | 6 days | — | $1K–$15K | 22.3 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2018-04-30 | 7 days | — | $1K–$15K | 40.4 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2018-04-27 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2014-12-19 | 0 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2014-07-28 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in SRE — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in SRE, 7 coincided with corporate insiders moving the same way within 60 days, and 7 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-06-17 | Winn Caroline Ann | Other | SELL | $9K | ↗ EDGAR |
| 2026-06-17 | Winn Caroline Ann | Other | SELL | $715K | ↗ EDGAR |
| 2026-05-18 | Ferrero Pablo | Director | SELL | $233K | ↗ EDGAR |
| 2026-05-14 | DAY DIANA L | C-suite | SELL 10b5-1 | $304K | ↗ EDGAR |
| 2026-04-01 | BIRD JUSTIN CHRISTOPHER | Other | SELL 10b5-1 | $109K | ↗ EDGAR |
| 2026-03-16 | Wold Dyan Z. | Other | SELL 10b5-1 | $147K | ↗ EDGAR |
| 2026-03-12 | Kirk Jennifer M | Director | BUY | $93K | ↗ EDGAR |
| 2026-03-11 | MARK RICHARD J | Director | BUY | $251K | ↗ EDGAR |
| 2026-03-11 | WARNER CYNTHIA J | Director | BUY | $232K | ↗ EDGAR |
| 2026-03-09 | Sedgwick Karen L | C-suite | SELL 10b5-1 | $90K | ↗ EDGAR |
| 2026-03-09 | Sedgwick Karen L | C-suite | SELL 10b5-1 | $250K | ↗ EDGAR |
| 2026-03-09 | Sedgwick Karen L | C-suite | SELL 10b5-1 | $111K | ↗ EDGAR |
| 2026-01-05 | Martin Jeffrey W | C-suite | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2026-01-05 | Martin Jeffrey W | C-suite | SELL 10b5-1 | $200K | ↗ EDGAR |
| 2026-01-05 | Martin Jeffrey W | C-suite | SELL 10b5-1 | $27K | ↗ EDGAR |
| 2026-01-02 | Martin Jeffrey W | C-suite | SELL 10b5-1 | $211K | ↗ EDGAR |
| 2026-01-02 | Martin Jeffrey W | C-suite | SELL 10b5-1 | $2.5M | ↗ EDGAR |
| 2025-11-24 | Sedgwick Karen L | C-suite | SELL 10b5-1 | $698K | ↗ EDGAR |
| 2025-11-19 | Winn Caroline Ann | Other | SELL 10b5-1 | $46K | ↗ EDGAR |
| 2025-11-19 | Wold Dyan Z. | Other | SELL | $138K | ↗ EDGAR |
| 2025-11-18 | Winn Caroline Ann | Other | SELL 10b5-1 | $504K | ↗ EDGAR |
| 2025-11-07 | Larroque Alexander Lisa | Other | SELL | $400K | ↗ EDGAR |
| 2025-09-29 | Sagara Kevin C. | Director | SELL 10b5-1 | $1.3M | ↗ EDGAR |
| 2025-09-15 | Sagara Kevin C. | Director | SELL 10b5-1 | $975K | ↗ EDGAR |
| 2025-09-15 | Sagara Kevin C. | Director | SELL 10b5-1 | $1.5M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-06-17 | Winn Caroline Ann Other | SELL | $9K |
| ◆ insider | 2026-06-17 | Winn Caroline Ann Other | SELL | $715K |
| ◆ insider | 2026-05-18 | Ferrero Pablo Director | SELL | $233K |
| ◆ insider | 2026-05-14 | DAY DIANA L C-suite 10b5-1 | SELL | $304K |
| ◆ insider | 2026-04-01 | BIRD JUSTIN CHRISTOPHER Other 10b5-1 | SELL | $109K |
| ◆ insider | 2026-03-16 | Wold Dyan Z. Other 10b5-1 | SELL | $147K |
| ◆ insider | 2026-03-12 | Kirk Jennifer M Director | BUY | $93K |
| ◆ insider | 2026-03-11 | MARK RICHARD J Director | BUY | $251K |
| ◆ insider | 2026-03-11 | WARNER CYNTHIA J Director | BUY | $232K |
| ◆ insider | 2026-03-09 | Sedgwick Karen L C-suite 10b5-1 | SELL | $90K |
| ◆ insider | 2026-03-09 | Sedgwick Karen L C-suite 10b5-1 | SELL | $250K |
| ◆ insider | 2026-03-09 | Sedgwick Karen L C-suite 10b5-1 | SELL | $111K |
| ◆ insider | 2026-01-05 | Martin Jeffrey W C-suite 10b5-1 | SELL | $1.8M |
| ◆ insider | 2026-01-05 | Martin Jeffrey W C-suite 10b5-1 | SELL | $200K |
| ◆ insider | 2026-01-05 | Martin Jeffrey W C-suite 10b5-1 | SELL | $27K |
| ◆ insider | 2026-01-02 | Martin Jeffrey W C-suite 10b5-1 | SELL | $211K |
| ◆ insider | 2026-01-02 | Martin Jeffrey W C-suite 10b5-1 | SELL | $2.5M |
| ◆ insider | 2025-11-24 | Sedgwick Karen L C-suite 10b5-1 | SELL | $698K |
| ◆ insider | 2025-11-19 | Winn Caroline Ann Other 10b5-1 | SELL | $46K |
| ◆ insider | 2025-11-19 | Wold Dyan Z. Other | SELL | $138K |
| ◆ insider | 2025-11-18 | Winn Caroline Ann Other 10b5-1 | SELL | $504K |
| ◆ insider | 2025-11-07 | Larroque Alexander Lisa Other | SELL | $400K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded SRE?
15 disclosed buys and 14 sells of SRE (Sempra) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade SRE?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.